Autolus Therapeutics (AUTL) Cash from Operations Growth (1y) (2018 - 2025)
Autolus Therapeutics (AUTL) Cash from Operations Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 158.60% |
| 10 | Autolus Therapeutics | 392.55 Mn | 91.84 Mn | -1.04 Mn | -77.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.47% |
| Sep 30, 2025 | 11.52% |
| Jun 30, 2025 | -42.48% |
| Mar 31, 2025 | -86.52% |
| Dec 31, 2024 | -52.76% |
| Sep 30, 2024 | -90.95% |
| Jun 30, 2024 | -33.91% |
| Mar 31, 2024 | 4.49% |
| Dec 31, 2023 | -70.49% |
| Sep 30, 2023 | -25.97% |
| Jun 30, 2023 | -23.82% |
| Mar 31, 2023 | -21.09% |
| Dec 31, 2022 | -59.05% |
| Sep 30, 2022 | 8.19% |
| Jun 30, 2022 | 15.85% |
| Mar 31, 2022 | 6.19% |
| Dec 31, 2021 | 66.97% |
| Sep 30, 2021 | 11.04% |
| Jun 30, 2021 | -35.93% |
| Mar 31, 2021 | -55.38% |